Slimline Unipolar Endocardial Pacing Lead, #30-407
510(k) K853223
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK853223 | Date17 Sep 1985 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Slimline Unipolar Endocardial Pacing Lead (#30-407) is a permanent pacemaker electrode designed for endocardial pacing. It delivers electrical stimulation to the heart’s inner lining to regulate cardiac rhythm in patients with bradycardia or conduction disorders, ensuring consistent pacing support through its unipolar configuration.
This lead is intended for use in cardiac electrophysiology procedures, typically implanted via the venous system to position the electrode tip against the endocardium. Supplied sterile and intended for single-use, it adheres to FDA 510(k) clearance under the traditional review pathway, classified as a Class III device (regulation number 870.3680). Compatibility with MRI is not specified, and proper storage requires adherence to manufacturer guidelines to maintain sterility and functionality.
Other devices from Telectronics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Slimline Unipolar Endocardial Pacing Lead (#30-407) in clinical practice?
The Slimline Unipolar Endocardial Pacing Lead (#30-407) is designed to deliver electrical stimulation to the heart’s inner lining (endocardium) to regulate abnormal slow heart rhythms (bradycardia) or conduction disorders. Its unipolar configuration ensures consistent pacing support by positioning the electrode tip against the endocardium, typically via venous implantation during cardiac electrophysiology procedures.
Is this device intended for reuse, or is it meant to be used only once?
The Slimline Unipolar Endocardial Pacing Lead (#30-407) is supplied sterile and explicitly intended for single-use only. Reuse is not recommended or supported by the manufacturer, as it could compromise sterility and device integrity.
How should this device be stored to maintain its sterility and functionality?
The manufacturer specifies that proper storage must adhere to their guidelines to preserve sterility and functionality. While exact storage conditions aren’t detailed, typical best practices for sterile medical devices—such as keeping the packaging sealed, avoiding contamination, and storing in a clean, dry environment—should be followed. Always refer to the manufacturer’s instructions for precise storage requirements.
What regulatory pathway was followed for FDA clearance of this device, and what classification does it hold?
The Slimline Unipolar Endocardial Pacing Lead (#30-407) was cleared under the traditional review pathway via an FDA 510(k) submission (K853223) and is classified as a Class III device under regulation number 870.3680. This classification reflects its role as a permanent pacemaker electrode, requiring stringent regulatory oversight.
Does this device have any known compatibility with MRI procedures?
The manufacturer does not specify MRI compatibility for the Slimline Unipolar Endocardial Pacing Lead (#30-407). Clinicians should exercise caution and consult the manufacturer’s guidelines or additional safety data before using this device in an MRI environment, as untested exposure could pose risks.